Your browser doesn't support javascript.
Ensuring continued progress for development of COVID-19 therapeutics in children.
Noel, Gary J; DeBiasi, Roberta L; Crandall, Wallace; Connor, Edward M.
  • Noel GJ; Institute for Advanced Clinical Trials for Children, Rockville, MD, USA. gary.noel@iactc.org.
  • DeBiasi RL; Children National Hospital, Washington, DC, USA.
  • Crandall W; Eli Lilly and Company, Indianapolis, IN, USA.
  • Connor EM; Institute for Advanced Clinical Trials for Children, Rockville, MD, USA.
Pediatr Res ; 90(6): 1112-1114, 2021 12.
Article in English | MEDLINE | ID: covidwho-1575172

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Drug Development / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Prognostic study Limits: Adolescent / Child / Humans Language: English Journal: Pediatr Res Year: 2021 Document Type: Article Affiliation country: S41390-021-01384-y

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Drug Development / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Prognostic study Limits: Adolescent / Child / Humans Language: English Journal: Pediatr Res Year: 2021 Document Type: Article Affiliation country: S41390-021-01384-y